Breakout Companies Power Our Future

Building the visual intelligence layer for regulated environments

Bringing natural control to robotic systems with AI

Automating chemical analysis to accelerate drug discovery and development

Advancing autoimmune care with precision therapies

Designing chemical catalysts using physics-based computation

Training foundation models for human biology

AI-enabled reproducibility infrastructure to unlock commercial distribution of scientific innovations

Harnessing enzymes to produce RNA-based therapeutics

Combining hardware and AI to diagnose sepsis in real time

Engineering B cells to produce therapeutics within the body

Reimagining the future of fertility with hormone-free IVF

Increasing performance chemical yields with biomanufacturing

Discovering drugs through millions of protein-protein interactions

Uncovering multifunctional drugs with advanced computation

Decoding chemical signatures into sensory reasoning models

Stabilizing biologics to address drug delivery’s core challenge *Acquired by Halozyme (HALO)*

Transforming carbon dioxide emissions into useful chemicals

Putting the immune system in a dish to improve drug discovery

Producing hard-to-source fats and oils with microalgae

Reprogramming the tumor microenvironment to eliminate cancer

Defeating migraines using minimally invasive neuromodulation

Investigating single-cell interactions to improve cell therapies

Finding new therapeutic routes to stop cancer for good

Driving plant-based meats and textiles with mycelium

Innovating materials with bio-design technology

Harnessing extracellular vesicles to deliver gene therapies in-vivo

Novel therapeutic approach to treating underlying causes of neurodegenerative diseases *IPO 2019*